Article: CLARITIN PERKS UP SCHERING-PLOUGH SALES

Article: Reportlinker Adds Top Ten World's Leading Animal Health ...
PR Newswire;  December 17, 2009 ;     700+ words ... ... BY COUNTRY/GEOGRAPHIC REGION TABLE SP-1: SCHERING-PLOUGH SALES BY PRODUCT GROUP TABLE SP-2: SCHERING-PLOUGH SALES GROWTH BY PRODUCT GROUP TABLE SP-3: SCHERING-PLOUGH SALES BY GEOGRAPHIC REGION TABLE VI-1: VIRBAC SALES BY GEOGRAPHIC ...

Article: Further Step in the Realignment of Bayer HealthCare: Bayer Enters ...
PR Newswire;  September 13, 2004 ;     700+ words ... ... will enhance the potential for Bayer's portfolio through seasonally-complementary detailing from an expanded Schering-Plough sales force. Bayer estimates that approximately 1,800 U.S.-based Bayer primary care sales and marketing positions will ...

Article: Bayer enters strategic pharmaceuticals alliance.
World Disease Weekly;  October 12, 2004 ;     700+ words ... ... will enhance the potential for Bayer's portfolio through seasonally complementary detailing from an expanded Schering-Plough sales force. Bayer estimates that approximately 1800 U.S.-based Bayer primary care sales and marketing positions will be ...

Article: FDA approves new cholesterol-lowering drug.(Knight Ridder ...
Knight Ridder/Tribune News Service;  July 24, 2004 ;     700+ words ... ... Just how well the pill sells will depend on pricing by the drug manufacturers, a joint venture between Merck and Schering-Plough. Sales representatives from Merck and from Schering-Plough will pitch the product to doctors, as will a "specialty" sales force ...

Article: Merck, Schering shares soar
The Record (Bergen County, NJ);  July 25, 2006 ;     700+ words ... ... based Merck cited strong sales of the cholesterol medicines Zetia and Vytorin, which it jointly markets with Schering-Plough. Sales of the allergy medicine Singulair also gave Merck a boost. The strong quarter led Merck to revise upward its full-year ...

Article: Merck & Co 1Q results saved by AZ payout.
Pharma Marketletter;  April 28, 2008 ;     700+ words ... ... Vytorin (ezetimibe and high-dose simvastatin) and Zetia (ezetimibe), which are marketed in partnership with Schering-Plough. Sales of the drugs dropped 25% from $1.2 billion vs $1.5 billion during the last quarter of 2007, although that figure ...

Article: bizworld: Chrysler plans include developing new electric ...
The Virginian Pilot;  September 20, 2008 ;     700+ words ... ... company said Friday in an e-mailed statement. The firings will take effect Oct. 1 and reduce the number of Schering-Plough sales representatives to 4,000. Miller will delay plans for drink MillerCoors says it's going to put plans for a new caffeine ...